ONCOLOGY / ANTICANCER DRUGS 

ONCOLOGY / ANTICANCER DRUGS 

Chemotherapy Agents

Capecitabine Decitabine Fludarabine Phosphate Gemcitabine Hydrochloride
Oxaliplatin Pemetrexed Disodium Irinotecan Hydrochloride Doxorubicin
Cisplatin Methotrexate Paclitaxel Docetaxel
  Trabectedin Carfilzomib  

Targeted Therapy

Acalabrutinib Ibrutinib Ponatinib Olaparib
Abemaciclib Apatinib Axitinib Cabozantinib
Lenvatinib Nilotinib Niraparib Palbociclib
Ribociclib Sunitinib Sorafenib Regorafenib
Osimertinib Lapatinib Afatinib Neratinib
Sotorasib Lorlatinib Capmatinib Pazopanib
Dasatinib Venetoclax Encorafenib Gilteritinib
Larotrectinib Selpercatinib Pralsetinib Dabrafenib
Ivosidenib Adagrasib Tazemetostat Futibatinib
Volitinib Lenacapavir Carfilzomib Bortezomib

Hormonal Therapy

Bicalutamide Anastrozole Exemestane Fulvestrant
Enzalutamide Abiraterone Tamoxifen Letrozole

 

Supportive Care

Palonosetron

Aprepitant Exemestane Calcium Levofolinate
Trilaciclib      

 

ONCOLOGY / ANTICANCER DRUGS 

Chemotherapy Agents

Capecitabine Decitabine Fludarabine Phosphate Gemcitabine Hydrochloride
Oxaliplatin Pemetrexed Disodium Irinotecan Hydrochloride Doxorubicin
Cisplatin Methotrexate Paclitaxel Docetaxel
  Trabectedin Carfilzomib  

Targeted Therapy

Acalabrutinib Ibrutinib Ponatinib Olaparib
Abemaciclib Apatinib Axitinib Cabozantinib
Lenvatinib Nilotinib Niraparib Palbociclib
Ribociclib Sunitinib Sorafenib Regorafenib
Osimertinib Lapatinib Afatinib Neratinib
Sotorasib Lorlatinib Capmatinib Pazopanib
Dasatinib Venetoclax Encorafenib Gilteritinib
Larotrectinib Selpercatinib Pralsetinib Dabrafenib
Ivosidenib Adagrasib Tazemetostat Futibatinib
Volitinib Lenacapavir Carfilzomib Bortezomib

Hormonal Therapy

Bicalutamide Anastrozole Exemestane Fulvestrant
Enzalutamide Abiraterone Tamoxifen Letrozole

 

Supportive Care

Palonosetron

Aprepitant Exemestane Calcium Levofolinate
Trilaciclib      

 

ONCOLOGY / ANTICANCER DRUGS 

Chemotherapy Agents

Capecitabine Decitabine Fludarabine Phosphate Gemcitabine Hydrochloride
Oxaliplatin Pemetrexed Disodium Irinotecan Hydrochloride Doxorubicin
Cisplatin Methotrexate Paclitaxel Docetaxel
  Trabectedin Carfilzomib  

Targeted Therapy

Acalabrutinib Ibrutinib Ponatinib Olaparib
Abemaciclib Apatinib Axitinib Cabozantinib
Lenvatinib Nilotinib Niraparib Palbociclib
Ribociclib Sunitinib Sorafenib Regorafenib
Osimertinib Lapatinib Afatinib Neratinib
Sotorasib Lorlatinib Capmatinib Pazopanib
Dasatinib Venetoclax Encorafenib Gilteritinib
Larotrectinib Selpercatinib Pralsetinib Dabrafenib
Ivosidenib Adagrasib Tazemetostat Futibatinib
Volitinib Lenacapavir Carfilzomib Bortezomib

Hormonal Therapy

Bicalutamide Anastrozole Exemestane Fulvestrant
Enzalutamide Abiraterone Tamoxifen Letrozole

 

Supportive Care

Palonosetron

Aprepitant Exemestane Calcium Levofolinate
Trilaciclib      

 

ONCOLOGY / ANTICANCER DRUGS 

Chemotherapy Agents

Capecitabine Decitabine Fludarabine Phosphate Gemcitabine Hydrochloride
Oxaliplatin Pemetrexed Disodium Irinotecan Hydrochloride Doxorubicin
Cisplatin Methotrexate Paclitaxel Docetaxel
  Trabectedin Carfilzomib  

Targeted Therapy

Acalabrutinib Ibrutinib Ponatinib Olaparib
Abemaciclib Apatinib Axitinib Cabozantinib
Lenvatinib Nilotinib Niraparib Palbociclib
Ribociclib Sunitinib Sorafenib Regorafenib
Osimertinib Lapatinib Afatinib Neratinib
Sotorasib Lorlatinib Capmatinib Pazopanib
Dasatinib Venetoclax Encorafenib Gilteritinib
Larotrectinib Selpercatinib Pralsetinib Dabrafenib
Ivosidenib Adagrasib Tazemetostat Futibatinib
Volitinib Lenacapavir Carfilzomib Bortezomib

Hormonal Therapy

Bicalutamide Anastrozole Exemestane Fulvestrant
Enzalutamide Abiraterone Tamoxifen Letrozole

 

Supportive Care

Palonosetron

Aprepitant Exemestane Calcium Levofolinate
Trilaciclib      

 

OUR CLIENTS

Let’s join hands to work Together

Let’s join hands to work Together

Let’s join hands to work Together